New Delhi: Drugs Controller General of India (DCGI) has given Cipla approval to import Moderna's COVID-19 vaccine for restricted emergency use in the country. Moderna’s COVID-19 vaccine will be ...
New Delhi: American pharmaceutical companies Pfizer and Moderna are in talks with the Centre over their COVID-19 vaccines, Niti Aayog member (health) Dr VK Paul said. “Approval to Pfizer and ...
Moderna said on Tuesday its COVID-19 vaccine has been found to be effective in children aged between 12 and 17, and that no new safety concerns emerged in a clinical ...
New Delhi: Moderna is likely to introduce a single-dose COVID-19 vaccine in India in 2022 while another US giant Pfizer will offer 5 crore jabs in 2021. At a time ...
Several Indian states, including Odisha, are keen to procure COVID-19 vaccines from the world market to speed up the process of inoculation. But it may not be smooth sailing for ...
New York: COVID-19 vaccines developed by BioNTech SE and Moderna lowered the infection risk by 80 per cent two weeks or more after the first jab, revealed the data from ...
Washington: Moderna has started dosing its mRNA-1273 COVID-19 vaccine on children aged six months to less than 12 years. "We are pleased to begin this Phase 2/3 study of mRNA-1273 ...
A study has found that Pfizer-BioNTech and Moderna’s COVID-19 vaccines can protect people from the new coronavirus variants, including one first detected in South Africa called B.1.351. According to a ...
Bhubaneswar: While some COVID-19 vaccines such as Oxford-AstraZeneca, Pfizer and Moderna have been launched for emergency use in parts of the world, here are some other vaccines in development. The ...
New York: Moderna Inc on Monday said it will produce at least 600 million doses of its COVID-19 vaccine. Earlier, it had decided to make 100 million doses. The company ...
Copyright © 2025 Frontier Media
